GENENTA SCIENCE SPA - ADR (GNTA) Stock Price & Overview
NASDAQ:GNTA • US36870W1009
Current stock price
The current stock price of GNTA is 0.6898 USD. Today GNTA is down by -0.03%. In the past month the price decreased by -19.22%. In the past year, price decreased by -81.02%.
GNTA Key Statistics
- Market Cap
- 16.164M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.44
- Dividend Yield
- N/A
GNTA Stock Performance
GNTA Stock Chart
GNTA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to GNTA. When comparing the yearly performance of all stocks, GNTA is a bad performer in the overall market: 97.5% of all stocks are doing better.
GNTA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to GNTA. The financial health of GNTA is average, but there are quite some concerns on its profitability.
GNTA Earnings
GNTA Forecast & Estimates
7 analysts have analysed GNTA and the average price target is 7.14 USD. This implies a price increase of 935.08% is expected in the next year compared to the current price of 0.6898.
GNTA Groups
Sector & Classification
GNTA Financial Highlights
Over the last trailing twelve months GNTA reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS increased by 3.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -40.37% | ||
| ROE | -71.82% | ||
| Debt/Equity | 0.62 |
GNTA Ownership
GNTA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.22 | 364.897B | ||
| AMGN | AMGEN INC | 15.34 | 183.284B | ||
| GILD | GILEAD SCIENCES INC | 15.97 | 172.309B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.74 | 109.705B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.57 | 80.376B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 43.91 | 42.375B | ||
| INSM | INSMED INC | N/A | 35.141B | ||
| NTRA | NATERA INC | N/A | 29.66B | ||
| BIIB | BIOGEN INC | 11.07 | 25.773B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.58 | 24.795B | ||
| MRNA | MODERNA INC | N/A | 19.79B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.082B | ||
| INCY | INCYTE CORP | 12.39 | 18.645B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About GNTA
Company Profile
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. The company is headquartered in Milan, Milano and currently employs 13 full-time employees. The company went IPO on 2021-12-15. The firm focuses on the development of lentivirus-based gene and cell therapies in cancer. The company uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The firm not only operates locally but also is present in global markets, including the United States.
Company Info
IPO: 2021-12-15
GENENTA SCIENCE SPA - ADR
Via dell’Annunciata 31
Milan MILANO IT
Employees: 13
GENENTA SCIENCE SPA - ADR / GNTA FAQ
Can you describe the business of GENENTA SCIENCE SPA - ADR?
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. The company is headquartered in Milan, Milano and currently employs 13 full-time employees. The company went IPO on 2021-12-15. The firm focuses on the development of lentivirus-based gene and cell therapies in cancer. The company uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The firm not only operates locally but also is present in global markets, including the United States.
Can you provide the latest stock price for GENENTA SCIENCE SPA - ADR?
The current stock price of GNTA is 0.6898 USD. The price decreased by -0.03% in the last trading session.
Does GNTA stock pay dividends?
GNTA does not pay a dividend.
What is the ChartMill rating of GENENTA SCIENCE SPA - ADR stock?
GNTA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the PE ratio for GNTA stock?
GENENTA SCIENCE SPA - ADR (GNTA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.44).
What is GENENTA SCIENCE SPA - ADR worth?
GENENTA SCIENCE SPA - ADR (GNTA) has a market capitalization of 16.16M USD. This makes GNTA a Nano Cap stock.
What is the ownership structure of GENENTA SCIENCE SPA - ADR (GNTA)?
You can find the ownership structure of GENENTA SCIENCE SPA - ADR (GNTA) on the Ownership tab.